These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1860104)

  • 21. Insulin antibodies in non-insulin-dependent diabetes mellitus: effect of treatment with semisynthetic human insulin.
    Lauritano AA; Clements RS; Bell D
    Clin Ther; 1989; 11(2):268-77. PubMed ID: 2660998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Insulin therapy: an ongoing topic].
    Waldhäusl W
    Wien Med Wochenschr; 1997; 147(9):199. PubMed ID: 9281231
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical investigations into the modification of the effect of endogenous and exogenous insulin by human proinsulin in type II and type I diabetics.
    Bellenberg S; Schröder KE; Schlüter KJ; Bottermann P; Zilker T; Gray P
    Horm Metab Res Suppl; 1988; 18():77-83. PubMed ID: 3056817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chronic insulin overdosage, hyperinsulinemia, atherosclerosis].
    Krasil'nikova EI; Almazov VA; Blagosklonnaia IV
    Klin Med (Mosk); 1996; 74(8):40-3. PubMed ID: 9036207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhaled human insulin ((insulin human [rDNA origin]) Inhalation Powder) in diabetes mellitus.
    Mathieu C
    Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):779-91. PubMed ID: 17014394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atherogenicity of insulin.
    Martin DB
    Diabetes Res Clin Pract; 1988; 4 Suppl 1():58-61. PubMed ID: 3042335
    [No Abstract]   [Full Text] [Related]  

  • 27. The impact of insulin upon atherosclerosis.
    Stout RW
    Horm Metab Res; 1994 Mar; 26(3):125-8. PubMed ID: 8005558
    [No Abstract]   [Full Text] [Related]  

  • 28. Cardiovascular safety of insulin: Between real-world data and reality.
    Mannucci E; Ferrannini E
    Diabetes Obes Metab; 2017 Sep; 19(9):1201-1204. PubMed ID: 28407342
    [No Abstract]   [Full Text] [Related]  

  • 29. Insulin resistance and atherosclerosis. Common roots for two common diseases?
    Taegtmeyer H
    Circulation; 1996 May; 93(10):1777-9. PubMed ID: 8635253
    [No Abstract]   [Full Text] [Related]  

  • 30. Guilt, or guilt by association? Insulin therapy in type 2 diabetes and death.
    Adler AI
    Lancet Diabetes Endocrinol; 2017 Jan; 5(1):7-8. PubMed ID: 27865757
    [No Abstract]   [Full Text] [Related]  

  • 31. Insulin: potential negative consequences of early routine use in patients with type 2 diabetes.
    Lebovitz HE
    Diabetes Care; 2011 May; 34 Suppl 2(Suppl 2):S225-30. PubMed ID: 21525460
    [No Abstract]   [Full Text] [Related]  

  • 32. Is insulin atherogenic?
    Orchard TJ
    Diabetologia; 1988 Jun; 31(6):404-5. PubMed ID: 3046978
    [No Abstract]   [Full Text] [Related]  

  • 33. [Roles of adipocytokines in the development of atherosclerosis].
    Yamauchi T
    Nihon Rinsho; 2007 Jul; 65 Suppl 7():63-70. PubMed ID: 17824015
    [No Abstract]   [Full Text] [Related]  

  • 34. Possible liver damage by biosynthetic human insulin.
    Shimizu H; Ohtani KI; Kudoh T; Tsuchiya T; Takahashi H; Sato N; Iriuchijima T; Mori M
    Diabetes Obes Metab; 1999 May; 1(3):179-80. PubMed ID: 11220297
    [No Abstract]   [Full Text] [Related]  

  • 35. Premature vascular degeneration in diabetes mellitus: pathogenesis, and relation to aging.
    SOLEZ C
    J Am Geriatr Soc; 1955 Oct; 3(10):804-10. PubMed ID: 13263098
    [No Abstract]   [Full Text] [Related]  

  • 36. --to: M. Koopmanschap: Coping with Type 2 diabetes: the patient's perspective. Diabetologia 45:S18-S22.
    Pouwer F; Adriaanse MC
    Diabetologia; 2003 Feb; 46(2):302-3. PubMed ID: 12627334
    [No Abstract]   [Full Text] [Related]  

  • 37. Insulin and atheroma--an update.
    Stout RW
    Lancet; 1987 May; 1(8541):1077-9. PubMed ID: 2883407
    [No Abstract]   [Full Text] [Related]  

  • 38. [Risk factors for atherosclerotic disease from the Japanese Elderly Diabetes Intervention Trial (J-EDIT)].
    Araki A
    Nihon Ronen Igakkai Zasshi; 2013; 50(1):53-5. PubMed ID: 23925092
    [No Abstract]   [Full Text] [Related]  

  • 39. A genetic marker for atherosclerosis?
    Mandrup-Poulsen T; Owerbach D; Mortensen SA; Johansen K; Meinertz H; Sørensen H; Nerup J
    Lancet; 1984 May; 1(8386):1131. PubMed ID: 6144867
    [No Abstract]   [Full Text] [Related]  

  • 40. A generalized allergic reaction due to zinc in insulin preparation.
    Bruni B; Campana M; Gamba S; Grassi G; Blatto A
    Diabetes Care; 1985; 8(2):201. PubMed ID: 3888566
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.